December 01, 2024, South Florida Hospital News and Healthcare Report
The Rising Threat of Nuclear Verdicts in Medical Malpractice: A Call for Tort Reform
Dr. Patricia Ares-Romero discusses the increasing trend of "nuclear verdicts"—jury awards exceeding $10 million—in medical malpractice cases.
Search
February 01, 2025, Today’s FDA
Nuclear Verdicts in Healthcare: How Social Inflation Impacts Physicians, Patients and the Future of Medicine
Bob White, President of The Doctors Company and TDC Group, discusses how desensitization to big numbers, eroding tort reform, and other factors are increasing healthcare costs.
July 27, 2024, PSQH Podcast
PSQH: The Podcast Episode 109 – The Overwhelming Flood of Patient Wearable Data
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses how data from wearables is affecting physicians and patient care.
Nov 30, 2022
Healthcare Inequities Post-Roe: Clinician Perspectives
Many states with abortion bans are also states with higher proportions of people of color, increasing the uneven impacts of the Dobbs decision, which overturned Roe v. Wade.
Shoulder Dystocia Documentation: Implementing a Protocol
Shoulder dystocia claims have traditionally been among the most problematic to defend.
Nov 27, 2023
Industry and Company News Fourth Quarter 2023
Announcements in the fourth quarter of 2023: ratings affirmations by AM Best and Fitch, two exclusive new endorsements, and Great Place to Work certification.
From
The Doctor’s Advocate
Plastic Surgery Risk Review Launched
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, today released “Plastic Surgery Claims: July Malpractice Risk Review,” the newest edition in a monthly series of specialty-focused analyses designed to support patient safety and clinical risk management.
AM Best Upgrades Financial Strength Ratings for The Doctors Company
AM Best has upgraded The Doctors Company’s financial strength rating (FSR) to A+ (Superior) from A (Excellent) and the long-term issuer credit rating (ICR) to “aa-” (Superior) from “a+” (Excellent). The outlook of these ratings is stable.
Exclusively Endorsed by the American College of Cardiology
The American College of Cardiology (ACC) exclusively endorses The Doctors Company’s medical malpractice insurance program.
Member Benefits for the American College of Surgeons
The American College of Surgeons (ACS) has offered The Doctors Company’s medical malpractice insurance as a member benefit since 2002.
